Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,248 | 7,039 | 9,292 | 6,429 | 8,538 |
| Marketable Securities | N/A | N/A | N/A | 209 | 1,893 |
| Other current assets | 249 | 0 | 0 | 0 | 50 |
| TOTAL | $6,863 | $7,645 | $10,151 | $6,726 | $10,575 |
| Non-Current Assets | |||||
| Investments And Advances | 37 | 37 | 37 | 33 | 410 |
| Other Non-Current Assets | 704 | 31 | 55 | 0 | 0 |
| TOTAL | $741 | $68 | $93 | $33 | $410 |
| Total Assets | $7,603 | $7,713 | $10,243 | $6,759 | $10,985 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 824 | 412 | 36 | 695 | 361 |
| Accrued Expenses | 623 | 391 | 614 | 693 | 507 |
| TOTAL | $1,453 | $831 | $679 | $1,388 | $868 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3 | 26 | 250 | 235 |
| TOTAL | $N/A | $3 | $26 | $250 | $235 |
| Total Liabilities | $1,453 | $834 | $705 | $1,638 | $1,103 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,258 | 13,171 | 4,404 | 3,302 | 959 |
| Common Shares | 2 | 1 | 0 | 0 | 0 |
| Retained earnings | -72,879 | -60,410 | -52,222 | -45,099 | -33,727 |
| Other shareholders' equity | 11 | 9 | 27 | 22 | 18 |
| TOTAL | $6,151 | $6,879 | $9,538 | $5,122 | $9,882 |
| Total Liabilities And Equity | $7,604 | $7,713 | $10,243 | $6,759 | $10,985 |